| 1 |
34683865 | Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. | 2021 Sep 28 |
2 |
| 2 |
25254417 | Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients. | 2015 Apr |
2 |
| 3 |
27137148 | Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment. | 2015 Sep |
3 |
| 4 |
24240480 | Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers. | 2014 Jan |
8 |
| 5 |
19022943 | Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5. | 2009 Feb |
8 |
| 6 |
15516294 | A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism. | 2004 Sep |
1 |